1. Home
  2. NOMD vs GENB Comparison

NOMD vs GENB Comparison

Compare NOMD & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nomad Foods Limited

NOMD

Nomad Foods Limited

HOLD

Current Price

$11.73

Market Cap

1.6B

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$15.64

Market Cap

1.9B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
NOMD
GENB
Founded
2014
2018
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.9B
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
NOMD
GENB
Price
$11.73
$15.64
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$12.50
$23.20
AVG Volume (30 Days)
1.5M
476.8K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
7.11%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.45
$16.58
P/E Ratio
$8.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.99
$11.00
52 Week High
$15.91
$18.18

Technical Indicators

Market Signals
Indicator
NOMD
GENB
Relative Strength Index (RSI) 53.02 59.66
Support Level $11.64 $11.82
Resistance Level $12.45 $16.75
Average True Range (ATR) 0.43 0.84
MACD -0.07 0.18
Stochastic Oscillator 48.66 98.18

Price Performance

Historical Comparison
NOMD
GENB

About NOMD Nomad Foods Limited

Nomad Foods Ltd is a packaged foods company that is involved in the business of manufacturing and distributing branded frozen foods in Western Europe. The company manufactures and markets frozen food products such as fish, vegetables, poultry, Ice Cream, and ready meals like pizza. It sells its products through large grocery retailers under the brand Birds Eye in the United Kingdom and Ireland, Findus in Italy, France, Spain, and Iglo in Germany and other continental markets. The company operates through a single segment being Frozen. The majority of the revenue is generated from the United Kingdom.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: